Thursday, September 28, 2017

Scythian Biosciences Corp. (TSXV: $SCYB.V) Forms Professional Athlete Advisory Committee

www.investorideas.com - News that inspires big Ideas

TORONTO - September 28, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) is pleased to announce the formation of its Professional Athlete Advisory Committee. The purpose of this committee is to bring together various, current, and former pro-athletes who have experienced or share concern for the pain and suffering associated with concussions that occur during sports competitions.
"The member's intimate knowledge and personal experience will lend Scythian and our research partners at the University of Miami great insight into the world of sports and the aftermath of head injuries. Bart Oates, who has been an Advisory Board member will head up this committee and lead in recruiting new inductees from Professional Football, Hockey, Basketball, Boxing, Soccer and more," commented Mr. Jonathan Gilbert, CEO of the Company.

http://www.investorideas.com/CO/SCYB/news/2017/09281ProfessionalAthlete.asp

No comments: